Bosutinib Impurity 5, with the CAS number 2095306-22-0, is a chemical compound that is typically associated with the pharmaceutical industry, particularly in the context of drug development and quality control. As an impurity, it may arise during the synthesis of bosutinib, a tyrosine kinase inhibitor used in the treatment of certain types of cancer. The characteristics of Bosutinib Impurity 5 include its molecular structure, which may feature specific functional groups that influence its chemical behavior and stability. It is important to analyze such impurities for their potential effects on the efficacy and safety of the primary drug. The compound's solubility, reactivity, and spectroscopic properties (such as NMR, IR, and mass spectrometry) are crucial for its identification and quantification. Regulatory guidelines often require the characterization of impurities to ensure that they are within acceptable limits, thereby ensuring the overall quality of the pharmaceutical product. Understanding the properties of Bosutinib Impurity 5 is essential for maintaining compliance with safety standards in drug manufacturing.

Bosutinib Impurity 5

2095306-22-0: Bosutinib Impurity 5, with the CAS number 2095306-22-0, is a chemical compound that is typically associated with the pharmaceutical industry, particularly in the context of drug development and quality control. As an impurity, it may arise during the synthesis of bosutinib, a tyrosine kinase inhibitor used in the treatment of certain types of cancer. The characteristics of Bosutinib Impurity 5 include its molecular structure, which may feature specific functional groups that influence its chemical behavior and stability. It is important to analyze such impurities for their potential effects on the efficacy and safety of the primary drug. The compound's solubility, reactivity, and spectroscopic properties (such as NMR, IR, and mass spectrometry) are crucial for its identification and quantification. Regulatory guidelines often require the characterization of impurities to ensure that they are within acceptable limits, thereby ensuring the overall quality of the pharmaceutical product. Understanding the properties of Bosutinib Impurity 5 is essential for maintaining compliance with safety standards in drug manufacturing.

CAS 2095306-22-0

Bosutinib Impurity 5

1,3-bis(2-Methoxy-5-nitrophenoxy)propane

Ref: ST-EA-CP-B80030